These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1674634

  • 1. Long-term follow-up after sustained monomorphic ventricular tachycardia: Causes, pump failure, and empiric antiarrhythmic therapy that modify survival.
    Leclercq JF, Coumel P, Denjoy I, Maisonblanche P, Cauchemez B, Chouty F, Leenhardt A, Slama R.
    Am Heart J; 1991 Jun; 121(6 Pt 1):1685-92. PubMed ID: 1674634
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS, Uricchio F, Estes NA.
    Am J Cardiol; 1989 May 01; 63(15):1052-7. PubMed ID: 2705375
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG, Felder SD, Figura I, Johnston DR, Waspe LE, Fisher JD.
    J Am Coll Cardiol; 1987 Jan 01; 9(1):169-74. PubMed ID: 3794093
    [Abstract] [Full Text] [Related]

  • 6. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R.
    Ann Cardiol Angeiol (Paris); 1996 Jan 01; 45(1):18-23. PubMed ID: 8815771
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E, Lacroix D, Klug D, Warembourg H, Kacet S, Lekieffre J.
    Arch Mal Coeur Vaiss; 1996 Apr 01; 89(4):435-44. PubMed ID: 8763003
    [Abstract] [Full Text] [Related]

  • 8. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M, Peter T, Weiss D, Nalos PC, Gang ES, Oseran DS, Mandel WJ.
    Am Heart J; 1990 Jan 01; 119(1):8-14. PubMed ID: 2296879
    [Abstract] [Full Text] [Related]

  • 9. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D.
    N Engl J Med; 1995 Jul 13; 333(2):77-82. PubMed ID: 7539890
    [Abstract] [Full Text] [Related]

  • 10. [Value of beta blockers in the treatment of recurrent ventricular tachycardia in cardiac insufficiency].
    Hermida JS, Coumel P, Leclercq JF, Cauchemez B, Maison-Blanche P, Leenhardt A, Slama R.
    Arch Mal Coeur Vaiss; 1987 Mar 13; 80(3):290-300. PubMed ID: 2887146
    [Abstract] [Full Text] [Related]

  • 11. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D, Robertson A, Hoffmann A, Pfisterer M.
    J Clin Pharmacol; 1991 Nov 13; 31(11):1105-8. PubMed ID: 1753016
    [Abstract] [Full Text] [Related]

  • 12. Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure.
    Stevenson WG, Middlekauff HR, Stevenson LW, Saxon LA, Woo MA, Moser D.
    Am Heart J; 1992 Jul 13; 124(1):123-30. PubMed ID: 1615794
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G.
    Circulation; 1992 Jul 13; 86(1):29-37. PubMed ID: 1617780
    [Abstract] [Full Text] [Related]

  • 14. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P, De Ponti R, Uriarte JA, Tondo C, Klersy C, Carbucicchio C, Storti C, Riva S, Longobardi M.
    Eur Heart J; 2002 Mar 13; 23(5):414-24. PubMed ID: 11846499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 13; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
    Kim SG, Felder SD, Figura I, Johnston DR, Mercando AD, Fisher JD.
    Am J Cardiol; 1987 Jun 01; 59(15):1314-8. PubMed ID: 3591686
    [Abstract] [Full Text] [Related]

  • 19. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.
    N Engl J Med; 1997 Nov 27; 337(22):1576-83. PubMed ID: 9411221
    [Abstract] [Full Text] [Related]

  • 20. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
    Olson PJ, Woelfel A, Simpson RJ, Foster JR.
    Am J Cardiol; 1993 Apr 01; 71(10):823-6. PubMed ID: 8456761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.